Swine Flu Vaccine From UK Aprooved

The EDR (European drugs regulator) has given the Green Light Sign for one of the UK's swine flu vaccines. Swine flu Vaccine from UK’s that made by GlaxoSmithKline has get an expert committee agreement. So, pandemrix can be used in adults and children over six months old and pregnant women.

The decision removes one of the last obstacles to getting the immunisation programme under way although licensing still needs to be formalised. The UK has bought 60 million doses of the vaccine. In addition, there are contracts for an as yet unapproved vaccine, Celvapan, produced by Baxter. It means the UK has provision for up to 132 million doses - enough for every person in the country.

Lately a vaccine are made by Novartis, Focetria, has also been recommended for licensing by the European Medicines Agency - but this is not planned to be used in the UK.

Final marketing authorisation for the vaccines still needs to be signed off by theEuropean Commission and is expected "as soon as possible". The EMEA said they were working with Baxter on some ongoing issues about their vaccine but hoped to be able to resolve those next week.

The vaccines have undergone an accelerated approval process as "mock-ups" of the vaccine had already been developed in preparation for a pandemic and tested in 6,000 people. Manufacturers have worked quickly to add the swine flu H1N1 strain to the mock versions. Early trial data had suggested good immune responses with just one dose of the vaccines.

The last case are extremely rising, imagine the number of new cases of swine flu in England has almost doubled over the last seven days to 9,000, official figures show.

In Scotland, the new weekly figures showed a slight increase from 6,180 to 7,034. Across the UK there have been 82 deaths. Although the figures are rising, they are as yet far short of the 100,000 cases a week seen in July.

Officials are still predicting a second wave of swine flu as winter approaches. But they hope to begin a vaccination programme sometime next month.